title: PET monitoring of liver directed selective internal radionuclide therapy for metastatic gastro-oesophageal cancer.
authors.affiliation: Department of Nuclear Medicine, Royal North Shore Hospital, New South Wales, Australia.
authors.forename: Dale L
authors.initials: DL
authors.lastname: Bailey
authors.affiliation: Sydney Medical School, University of Sydney, Australia.
authors.forename: Adrian
authors.initials: A
authors.lastname: Lee
authors.affiliation: Sydney Medical School, University of Sydney, Australia Thoracic Oncology Service, Developmental Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
authors.forename: Bob T
authors.initials: BT
authors.lastname: Li
authors.affiliation: Sydney Medical School, University of Sydney, Australia Department of Medical Oncology, Royal North Shore Hospital, New South Wales, Australia.
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Clarke
mesh_terms: D000368:Aged; D004938:Esophageal Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D000072078:Positron Emission Tomography Computed Tomography; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
chemical_list: D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes